These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7633276)

  • 1. Effects of the submarine environment on renal-stone risk factors and vitamin D metabolism.
    Dlugos DJ; Perrotta PL; Horn WG
    Undersea Hyperb Med; 1995 Jun; 22(2):145-52. PubMed ID: 7633276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of hypophosphatemia in calcium nephrolithiasis.
    Yamakawa K; Kawamura J
    Mol Urol; 2000; 4(4):365-70. PubMed ID: 11156704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seasonal variations in urinary risk factors among patients with nephrolithiasis.
    Stuart RO 2nd ; Hill K; Poindexter J; Pak CY
    J Lithotr Stone Dis; 1991 Jan; 3(1):18-27. PubMed ID: 11536932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D supplementation in underway submariners.
    Duplessis CA; Harris EB; Watenpaugh DE; Horn WG
    Aviat Space Environ Med; 2005 Jun; 76(6):569-75. PubMed ID: 15945402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of parathyroid hormone and vitamin D in essential hypertension.
    Young EW; Morris CD; Holcomb S; McMillan G; McCarron DA
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):957-64. PubMed ID: 8845076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.
    Del Valle E; Negri AL; Aguirre C; Fradinger E; Zanchetta JR
    Hemodial Int; 2007 Jul; 11(3):315-21. PubMed ID: 17576296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the physicochemical risk for renal stone disease during pregnancy.
    Smith CL; Kristensen C; Davis M; Abraham PA
    Clin Nephrol; 2001 Mar; 55(3):205-11. PubMed ID: 11316240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sodium excretion in children with lithogenic disorders].
    Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
    Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on citrate metabolism in normal subjects and kidney stone patients.
    Minisola S; Rossi W; Pacitti MT; Scarnecchia L; Bigi F; Carnevale V; Mazzuoli G
    Miner Electrolyte Metab; 1989; 15(5):303-8. PubMed ID: 2811789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal stone risk in a simulated microgravity environment: impact of treadmill exercise with lower body negative pressure.
    Monga M; Macias B; Groppo E; Kostelec M; Hargens A
    J Urol; 2006 Jul; 176(1):127-31. PubMed ID: 16753386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of ultraviolet B radiation treatments on calcium excretion and vitamin D metabolites in kidney stone formers.
    Varghese M; Rodman JS; Williams JJ; Brown A; Carter DM; Zerwekh JE; Pak CY
    Clin Nephrol; 1989 May; 31(5):225-31. PubMed ID: 2736812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excretion of inhibitors of calcification in urine. Part I. Findings in control subjects and patients with renal stones.
    Oreopoulos DG; Walker D; Akriotis DJ; Roncari DA; Husdan H; Symvoulidis A; Deveber GA; Rapoport A; Reid DB
    Can Med Assoc J; 1975 Apr; 112(7):827-31. PubMed ID: 1122457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractional calcium absorption is increased in girls with Rett syndrome.
    Motil KJ; Schultz RJ; Abrams S; Ellis KJ; Glaze DG
    J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):419-26. PubMed ID: 16641581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum levels of Vitamin D in infants with urolithiasis.
    Fallahzadeh MH; Zare J; Al-Hashemi GH; Derakhshan A; Basiratnia M; Arasteh MM; Fallahzadeh MA; Fallahzadeh MK
    Iran J Kidney Dis; 2012 May; 6(3):186-91. PubMed ID: 22555482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of urinary stone disease by physical exercise.
    Sriboonlue P; Prasongwatana V; Tosukhowong P; Tungsanga K; Bovornpadoongkitti S
    Southeast Asian J Trop Med Public Health; 1996 Mar; 27(1):172-7. PubMed ID: 9031423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute oral calcium-sodium citrate load in healthy males. Effects on acid-base and mineral metabolism, oxalate and other risk factors of stone formation in urine.
    Schwille PO; Schmiedl A; Herrmann U; Schwille R; Fink E; Manoharan M
    Methods Find Exp Clin Pharmacol; 1997; 19(6):417-27. PubMed ID: 9385591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.